E. Megías-Roda

The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells

J. Bosch-Barrera, G. Velasco, J. Lizcano, 2020, Autophagy.

ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models

J. Lizcano, M. Yeste-Velasco, T. Puig, 2022, Cancer communications.

The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival

J. Lizcano, X. Dolcet, J. Bayascas, 2022, bioRxiv.

Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.

C. Moiola, N. Eritja, X. Matías-Guiu, 2019, Gynecologic oncology.

ERK5 Inhibition Induces Autophagy-Mediated Cancer Cell Death by Activating ER Stress

J. Lizcano, P. Muñoz-Guardiola, E. Megías-Roda, 2021, Frontiers in Cell and Developmental Biology.

The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer

P. Gascón, M. Mancino, P. Bragado, 2020, International journal of cancer.